These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36139641)

  • 1. Real-World Outcomes and Treatments Patterns Prior and after the Introduction of First-Line Immunotherapy for the Treatment of Metastatic Non-Small Cell Lung Cancer.
    Danesi V; Massa I; Foca F; Delmonte A; Crinò L; Bronte G; Ragonesi M; Maltoni R; Manunta S; Cravero P; Andrikou K; Priano I; Balzi W; Gentili N; Burke T; Altini M
    Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-World Clinical Outcomes in Patients with Locally Advanced or Metastatic Merkel Cell Carcinoma Treated in U.S. Oncology Clinical Practices: Results from SPEAR-Merkel.
    Bhanegaonkar A; Liu FX; Boyd M; Fulcher N; Kim R; Krulewicz S; Smith J; Cowey CL
    Oncologist; 2021 Sep; 26(9):e1633-e1643. PubMed ID: 34101298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-world observational study of current treatment patterns and outcomes in recurrent or locally advanced/metastatic non-small cell lung cancer.
    Bazhenova L; Kish J; Cai B; Caro N; Feinberg B
    Cancer Treat Res Commun; 2022; 33():100637. PubMed ID: 36162323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of real-world data (RWD) analysis on efficacy and post-progression outcomes with pembrolizumab plus chemo vs chemo alone in metastatic non-squamous non-small cell lung cancer with PD-L1 < 50.
    Attili I; Valenza C; Santoro C; Antonarelli G; Trillo Aliaga P; Del Signore E; Catania C; Spitaleri G; Passaro A; de Marinis F
    Front Oncol; 2022; 12():980765. PubMed ID: 36033444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Real-World Outcomes of First-Line Pembrolizumab Monotherapy for Metastatic Non-Small Cell Lung Cancer With ≥50% Expression of Programmed Cell Death-Ligand 1.
    Velcheti V; Hu X; Yang L; Pietanza MC; Burke T
    Front Oncol; 2022; 12():834761. PubMed ID: 35402266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of PD-(L)1 inhibitors alone or in combination with platinum-doublet chemotherapy in first-line (1L) non-squamous non-small-cell lung cancer (Nsq-NSCLC) with PD-L1-high expression using real-world data.
    Pérol M; Felip E; Dafni U; Polito L; Pal N; Tsourti Z; Ton TGN; Merritt D; Morris S; Stahel R; Peters S
    Ann Oncol; 2022 May; 33(5):511-521. PubMed ID: 35218887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First-line Systemic Therapy Following Adjuvant Immunotherapy in Renal Cell Carcinoma: An International Multicenter Study.
    El Zarif T; Semaan K; Xie W; Eid M; Zarba M; Issa W; Zhang T; Nguyen CB; Alva A; Fahey CC; Beckermann KE; Karam JA; Campbell MT; Procopio G; Stellato M; Buti S; Zemankova A; Melichar B; Massari F; Mollica V; Venugopal B; Ebrahimi H; de Velasco G; Gurney HP; De Giorgi U; Parikh O; Winquist E; Master V; Garcia AR; Cutuli HJ; Ferguson TR; Gross-Goupil M; Baca SC; Pal SK; Braun DA; McKay RR; Heng DYC; Choueiri TK
    Eur Urol; 2024 Aug; ():. PubMed ID: 39147674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-world outcomes of immunotherapy-based regimens in first-line advanced non-small cell lung cancer.
    Waterhouse D; Lam J; Betts KA; Yin L; Gao S; Yuan Y; Hartman J; Rao S; Lubinga S; Stenehjem D
    Lung Cancer; 2021 Jun; 156():41-49. PubMed ID: 33894493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-world treatment patterns and outcomes among individuals receiving first-line pembrolizumab therapy for recurrent/metastatic head and neck squamous cell carcinoma.
    Black CM; Hanna GJ; Wang L; Ramakrishnan K; Goto D; Turzhitsky V; Hair GM
    Front Oncol; 2023; 13():1160144. PubMed ID: 37284189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Healthcare Costs and Resource Utilisation of Italian Metastatic Non-Small Cell Lung Cancer Patients.
    Gentili N; Balzi W; Foca F; Danesi V; Altini M; Delmonte A; Bronte G; Crinò L; De Luigi N; Mariotti M; Verlicchi A; Burgio MA; Roncadori A; Burke T; Massa I
    Cancers (Basel); 2024 Jan; 16(3):. PubMed ID: 38339345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health outcomes and healthcare resource utilization among Veterans with stage IV non-small cell lung cancer treated with second-line chemotherapy versus immunotherapy.
    Williams CD; Allo MA; Gu L; Vashistha V; Press A; Kelley M
    PLoS One; 2023; 18(2):e0282020. PubMed ID: 36809528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Real-World Data Study to Evaluate Treatment Patterns, Clinical Characteristics and Survival Outcomes for First- and Second-Line Treatment in Locally Advanced and Metastatic Urothelial Cancer Patients in Germany.
    Niegisch G; Gerullis H; Lin SW; Pavlova J; Gondos A; Rudolph A; Haas G; Hennies N; Kramer MW
    J Cancer; 2018; 9(8):1337-1348. PubMed ID: 29721042
    [No Abstract]   [Full Text] [Related]  

  • 13. Biomarker Testing Patterns and Treatment Outcomes in Patients With Advanced Non-Small Cell Lung Cancer and
    Asad Zadeh Vosta Kolaei F; Cai B; Kanakamedala H; Kim J; Doban V; Zhang S; Shi M
    Front Oncol; 2022; 12():786124. PubMed ID: 35280795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Effectiveness of Second-line Sunitinib Following Immuno-oncology Therapy in Patients with Metastatic Renal Cell Carcinoma: A Real-world Study.
    Wells JC; Dudani S; Gan CL; Stukalin I; Azad AA; Liow E; Donskov F; Yuasa T; Pal SK; De Velasco G; Hansen AR; Beuselinck B; Kollmannsberger CK; Powles T; McGregor BA; Duh MS; Huynh L; Heng DYC
    Clin Genitourin Cancer; 2021 Aug; 19(4):354-361. PubMed ID: 33863648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frontline pembrolizumab monotherapy for metastatic non-small cell lung cancer with PD-L1 expression ≥50%: real-world outcomes in a US community oncology setting.
    Gadgeel SM; Rai P; Annavarapu S; Alam S; Goldschmidt JH; West HJ; Santorelli M; Martins RE
    Front Oncol; 2024; 14():1298603. PubMed ID: 38525422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond clinical trials: real-world impact of immunotherapy on NSCLC in Jordan.
    Abu Hejleh T; AlSawalha K; Abdel Hafiz S; Al-Batsh T; Abu Hejleh R; Yaser S; Abu Jazar H; Khader J; Alnsour A; Mohamad I; Abdel Jalil R; Abu-Shanab A; Gharaibeh A; Abu Shattal M; Alibraheem A; Haddad H; Mahmoud N; Obeidat S; Al-Jaghbeer MJ; Furqan M; Cortellini A; Velcheti V; Al-Rabi K
    Front Oncol; 2024; 14():1369126. PubMed ID: 38746680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer.
    Ferrara R; Imbimbo M; Malouf R; Paget-Bailly S; Calais F; Marchal C; Westeel V
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013257. PubMed ID: 33316104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-world outcomes of different lines and sequences of treatment in BRAF-positive advanced melanoma patients.
    Betof Warner A; Tarhini A; Kang B; Nakasato A; Ling YL; Shah R; Tang J; Patel J
    Melanoma Res; 2023 Feb; 33(1):38-49. PubMed ID: 36545921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between Smoking History and Overall Survival in Patients Receiving Pembrolizumab for First-Line Treatment of Advanced Non-Small Cell Lung Cancer.
    Popat S; Liu SV; Scheuer N; Gupta A; Hsu GG; Ramagopalan SV; Griesinger F; Subbiah V
    JAMA Netw Open; 2022 May; 5(5):e2214046. PubMed ID: 35612853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Multicenter Study Assessing the Real-World Use and Effectiveness of First-Line Chemotherapy Plus Immunotherapy in Advanced Small-Cell Lung Cancer (SCLC) Patients.
    Porte M; Vaudron A; Crequit P; Vaugier L; Chatellier T; Fronteau C; Raimbourg J; Goronflot T; Bennouna J; Pons-Tostivint E
    Clin Lung Cancer; 2024 Mar; 25(2):e101-e111.e2. PubMed ID: 38072729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.